Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GPCR19 agonist increases in number of immune-regulatory myeloid cells and their expression of immune checkpoint molecule

ABSTRACT: GPCR19 pathway has been implicated in regulating various inflammation. However, the exact mechanism of immune regulation by GPCR19 pathway has not been elucidated in detail. Here, we report that intravenous infusion of a GPCR19 agonist, sodium taurodeoxycholate (STDC), decreases serum pro-inflammatory cytokines, normalizes hypotension, protects against renal injury and prolongs mice survival during sepsis.

ORGANISM(S): Mus musculus

PROVIDER: GSE92948 | GEO | 2018/12/26

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Safety and Efficacy of Intravenous Norepinephrine for Orthostatic Hypotension - ARD 6104

Project description:Safety and Efficacy of Intravenous Norepinephrine for Orthostatic Hypotension - ARD 6104

| PRJNA514385 | ENA

Safety and Efficacy of Intravenous Norepinephrine for Orthostatic Hypotension - ARD 6104

Project description:Safety and Efficacy of Intravenous Norepinephrine for Orthostatic Hypotension - ARD 6104

| PRJNA514386 | ENA

Uncovering the mechanisms responsible for intravenous paracetamol-induced hypotension

Project description:Intravenous (IV) administration of paracetamol (APAP) is well-documented to cause severe hypotension, particularly in critically ill patients. We have previously shown that a metabolite of APAP – N-acetyl-p-benzoquinone imine (NAPQI) – is a potent vasodilator, but whether APAP can be metabolised to NAPQI in the vasculature is unknown. Here, we show that NAPQI can be generated by the human coronary endothelial cells (HCAECs) treated with APAP, by staining for APAP-adducts and showing a drop in cell viability and glutathione levels, similar to direct NAPQI treatment. We show that glutathione depletion following APAP treatment is caused the cytochrome p450 enzymes (CYPs) expressed in HCAECs by utilizing a blocker of the CYPs, ketoconazole. Furthermore, mass spectrometry analysis of HCAECs treated with 10 mM APAP for 24h shows upregulation of proteins involved in redox biology and the pentose phosphate pathway, as well as CYP20A1 and POR. Lastly, we show that myeloperoxidase can also metabolize APAP to NAPQI at physiologically relevant concentrations. Taken together, this study shows that APAP can be metabolized within the vasculature to the potent vasodilator NAPQI. We suggest that this is the mechanism by which critically ill patients can present with IV APAP-induced hypotension.

2025-05-20 | PXD047218 | Pride

The effect of local anaesthetics on blood pressure volatility IV lidocaine vs epidural anesthesia in patients undergoing colorectal surgery

Project description:Interventions: intravenous lidocaine infusion during general anesthesia for colon surgery,combined general and epidural anesthesia for colon surgery;Active Comparator Procedure/Surgery,Active Comparator Procedure/Surgery;IV lidocaine,epidural anesthesia Primary outcome(s): Haemodynamics stability intraoperative period incidence of hypotension Study Design: Randomized

| 2567506 | ecrin-mdr-crc

Time-dependent changes in gene expression after endotoxinic challenge followed by LR12-scrambled or LR12 treatment.

2013-06-27 | GSE48311 | GEO

Paracetamol metabolism by endothelial cells – potential mechanism underlying intravenous paracetamol-induced hypotension

Project description:We have shown previously that a metabolite of acetaminophen (APAP), N-acetyl-p-benzoquinone imine (NAPQI), is a potent vasodilator, which could underlie the hypotension observed when APAP is administered intravenously. However, it is unknown whether APAP metabolism to NAPQI is possible in the vasculature. In this study, we examine the hypothesis that APAP is metabolized by cytochrome P450 enzymes within the endothelium, which may be accelerated in critically ill patients by the presence of elevated myeloperoxidase (MPO). Exposure of human coronary artery endothelial cells (HCAECs) to APAP resulted in the formation of protein-bound APAP adducts, together with a loss of metabolic activity. Proteomic analysis of HCAECs exposed to APAP showed upregulation of CYP20A1 and cytochrome P450 reductase (POR), together with proteins involved in the pentose phosphate pathway and maintaining redox homeostasis. Furthermore, proteomic analysis of mesenteric arteries and livers from rats administered intravenous APAP showed that APAP metabolism likely took place in the vascular wall and not in the liver. Moreover, similar proteomic pathway changes were identified in HCAECs and mesenteric arteries. Intracellular thiols were depleted in HCAECs upon APAP treatment, which was partially attenuated by ketoconazole, consistent with the involvement of cytochrome P450 enzymes (CYP) in the metabolism of APAP to a thiol-reactive metabolite such as NAPQI. Evidence was also obtained for the metabolism of APAP to a thiol-reactive intermediate by MPO, in accordance with NAPQI formation. Taken together, these data provide a putative mechanism to explain the presentation of hypotension in critically ill patients following IV APAP administration.

2025-05-20 | PXD058085 | Pride

Brief Hydrocortisone Infusion Differentially Influences Blood Leukocyte and Monocyte Gene Expression Before and After Endotoxin Administration in Humans (supported by NIH grant GM34695)

Project description:Fourteen human subjects (18-40 years of age) were studied. The control group (saline + LPS [n = 7]) received a 12 hour infusion of saline and the experimental group (cortisol + LPS [n = 7]) received a 12 hour infusion of cortisol (3 ug/kg/min). After 6 hours of saline or cortisol infusion, intravenous lipopolysaccharide (2 ng/kg) was administered to all subjects. Blood samples were collected at -24 hours, 0 hours, 6 hours and 24 hours relative to LPS administration at 0 hours. Leukocytes and monocytes were isolated from these blood samples, total RNA extracted, and microarray analyses performed using Affymetrix Focus GeneChips. Blood samples were collected at (-24)hr, 0hr, 6hr, and 24hr in relation to the LPS infusion. For both saline and cortisol treated subjects, infusion was started at (-6) hr and continued to (+6) hr.

2010-06-08 | E-GEOD-21909 | biostudies-arrayexpress

Brief Hydrocortisone Infusion Differentially Influences Blood Leukocyte and Monocyte Gene Expression Before and After Endotoxin Administration in Humans (supported by NIH grant GM34695)

Project description:Fourteen human subjects (18-40 years of age) were studied. The control group (saline + LPS [n = 7]) received a 12 hour infusion of saline and the experimental group (cortisol + LPS [n = 7]) received a 12 hour infusion of cortisol (3 µg/kg/min). After 6 hours of saline or cortisol infusion, intravenous lipopolysaccharide (2 ng/kg) was administered to all subjects. Blood samples were collected at -24 hours, 0 hours, 6 hours and 24 hours relative to LPS administration at 0 hours. Leukocytes and monocytes were isolated from these blood samples, total RNA extracted, and microarray analyses performed using Affymetrix Focus GeneChips®.

2010-05-21 | GSE21909 | GEO

Time-dependent changes in gene expression after endotoxinic challenge followed by LR12-scrambled or LR12 treatment.

Project description:Gene expression assessment in blood from male Cynomolgus monkey after endotoxin challenge followed by intravenous infusion with peptide control (LR12-scrambled) or LR12. The samples were analyzed at different time-points: 0, 2, 4 and 8 hours 56 samples : 4 time points, 4 vehicle samples/time point, 4 peptide control samples/time point, 6 LR12 samples/time point

2013-06-27 | E-GEOD-48311 | biostudies-arrayexpress

A Novel Model of Common TLR4- and Injury induced transcriptional themes in Human Leukocytes (supported by NIH grant GM34695)

Project description:Fifteen human volunteer subjects (18-40 years of age) and 5 Trauma patients were studied. One volunteer group (saline + LPS [n = 8]) received a 12 hour infusion a second volunteer group (cortisol + LPS [n = 7]) received a 12 hour infusion of cortisol (3 Âµg/kg/min). After 6 hours of saline or cortisol infusion, intravenous lipopolysaccharide (2 ng/kg) was administered to all subjects. Blood samples were collected at 0 hours, 6 hours and 24 hours relative to LPS administration at 0 hours. Blood samples were drawn from a grounp of Trauma patients shortly (day1-5) after admission and later in their ICU stay (day 5-7). Leukocytes were isolated from these blood samples, total RNA extracted, and microarray analyses performed using Affymetrix Focus GeneChipsÂ® on samples yeilding sufficent quantity and quality RNA for analysis. Blood samples were collected at 0hr, 6hr, and 24hr in relation to the LPS infusion. For both saline and cortisol treated subjects, infusion was started at (-6) hr and continued to (+6) hr.

2010-06-23 | E-GEOD-22278 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data